Additionally, a study utilizing a CT and MRI radiomics-based extreme gradient boosting (XGBoost) classifier demonstrated that the levels of tumor-infiltrating CD8+ T cells in patients with pancreatic ductal adenocarcinoma (PDAC) could be effectively predicted. This evidence concerns the gene CD8A and neoplasm.